Clinical Trial Update: Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study [Phase 3]

View source ↗

Summary

A Phase 3 pilot study evaluating denosumab for improving bone mineral density in women with anorexia nervosa has completed, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa
• Eating Disorders

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bone Density, Bone Loss | Phase 3 | Status: COMPLETED | Results posted: 2022-10-12